New vaccines for yellow fever and rabies enter first human tests
NCT ID NCT06998004
First seen Apr 23, 2026 · Last updated May 01, 2026 · Updated 2 times
Summary
This early-stage study tested two new vaccines—one for yellow fever and one for rabies—in 112 healthy adults aged 18 to 40. The main goal was to check if the vaccines are safe and how well they trigger an immune response. Participants received either the vaccine or a placebo, and researchers monitored for side effects and immune reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for the Evaluation of Vaccination (CEV)
Antwerp, Belgium
-
University Hospital Ghent - Centrum voor Vaccinologie (CEVAC)
Ghent, Belgium
Conditions
Explore the condition pages connected to this study.